Eli Lilly and Co's Options: A Look at What the Big Money Is Thinking
Eli Lilly and Co's Options: A Look at What the Big Money Is Thinking
Deep-pocketed investors have adopted a bearish approach towards Eli Lilly and Co (NYSE:LLY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LLY usually suggests something big is about to happen.
财力雄厚的投资者对礼来公司（纽约证券交易所代码：LLY）采取了看跌的态度，这是市场参与者不容忽视的。我们对本辛加公开期权记录的追踪今天揭示了这一重大举措。这些投资者的身份仍然未知，但是LLY的如此重大变动通常表明即将发生重大事件。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for Eli Lilly and Co. This level of activity is out of the ordinary.
我们从今天的观察中收集了这些信息，当时Benzinga的期权扫描仪重点介绍了礼来公司的30项非同寻常的期权活动。这种活动水平与众不同。
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 46% bearish. Among these notable options, 4 are puts, totaling $304,322, and 26 are calls, amounting to $3,313,701.
这些重量级投资者的总体情绪存在分歧，33％的人倾向于看涨，46％的人倾向于看跌。在这些值得注意的期权中，有4个是看跌期权，总额为304,322美元，26个是看涨期权，总额为3,313,701美元。
Predicted Price Range
预测的价格区间
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $400.0 and $1080.0 for Eli Lilly and Co, spanning the last three months.
在评估了交易量和未平仓合约之后，很明显，主要市场走势者将注意力集中在礼来公司过去三个月的400.0美元至1080.0美元之间的价格区间上。
Volume & Open Interest Trends
交易量和未平仓合约趋势
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 379.43, with a total volume reaching 283.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $400.0 to $1080.0, throughout the last 30 days.
在今天的交易背景下，礼来公司期权的平均未平仓合约为379.43张，总成交量达到283.00。随附的图表描绘了过去30天内位于行使价走廊内从400.0美元到1080.0美元的高价值交易的看涨和看跌期权交易量以及未平仓合约的变化。
Eli Lilly and Co Call and Put Volume: 30-Day Overview
礼来公司看涨和看跌交易量：30天概述
Biggest Options Spotted:
发现的最大选择：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | NEUTRAL | 08/16/24 | $40.3 | $38.85 | $39.5 | $950.00 | $691.2K | 987 | 0 |
| LLY | CALL | TRADE | BULLISH | 08/02/24 | $23.75 | $21.55 | $23.0 | $950.00 | $402.5K | 105 | 9 |
| LLY | CALL | SWEEP | BEARISH | 07/19/24 | $55.25 | $51.65 | $51.05 | $900.00 | $392.5K | 1.2K | 0 |
| LLY | CALL | SWEEP | NEUTRAL | 01/17/25 | $91.85 | $88.85 | $90.35 | $960.00 | $225.6K | 463 | 0 |
| LLY | CALL | SWEEP | BULLISH | 10/18/24 | $240.9 | $238.2 | $240.9 | $720.00 | $216.7K | 158 | 0 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 莉莉 | 打电话 | 贸易 | 中立 | 08/16/24 | 40.3 美元 | 38.85 美元 | 39.5 美元 | 950.00 美元 | 691.2 万美元 | 987 | 0 |
| 莉莉 | 打电话 | 贸易 | 看涨 | 08/02/24 | 23.75 美元 | 21.55 美元 | 23.0 美元 | 950.00 美元 | 402.5 万美元 | 105 | 9 |
| 莉莉 | 打电话 | 扫 | 粗鲁的 | 07/19/24 | 55.25 美元 | 51.65 美元 | 51.05 美元 | 900.00 美元 | 392.5 万美元 | 1.2K | 0 |
| 莉莉 | 打电话 | 扫 | 中立 | 01/17/25 | 91.85 美元 | 88.85 美元 | 90.35 美元 | 960.00 美元 | 225.6 万美元 | 463 | 0 |
| 莉莉 | 打电话 | 扫 | 看涨 | 10/18/24 | 240.9 美元 | 238.2 美元 | 240.9 美元 | 720.00 美元 | 21.67 万美元 | 158 | 0 |
About Eli Lilly and Co
关于 Eli Lilly and Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
礼来是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。礼来公司的主要产品包括治疗癌症的Verzenio；用于治疗糖尿病的Mounjaro、Zepbound、Jardiance、Trulicity、Humalog和Humulin；以及用于免疫学的Taltz和Olumiant。
Eli Lilly and Co's Current Market Status
Eli Lilly and Co的当前市场状况
- With a trading volume of 309,671, the price of LLY is down by -0.09%, reaching $949.65.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 23 days from now.
- LLY的交易量为309,671美元，价格下跌了-0.09％，至949.65美元。
- 当前的RSI值表明该股可能已被超买。
- 下一份收益报告定于即日起23天后发布。
Expert Opinions on Eli Lilly and Co
关于 Eli Lilly and Co 的专家意见
5 market experts have recently issued ratings for this stock, with a consensus target price of $912.6.
5位市场专家最近发布了该股的评级，共识目标价为912.6美元。
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $885.
- An analyst from Morgan Stanley has decided to maintain their Overweight rating on Eli Lilly and Co, which currently sits at a price target of $1023.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $885.
- 坎托·菲茨杰拉德的一位分析师将其评级下调至增持，新的目标股价为885美元，这反映了人们的担忧。
- 摩根士丹利的一位分析师已决定维持对礼来公司的增持评级，目前的目标股价为1023美元。
- 坎托·菲茨杰拉德的一位分析师将其评级下调至增持，目标股价为885美元。
- 坎托·菲茨杰拉德的一位分析师已将其评级下调至增持，将目标股价调整为885美元。
- 坎托·菲茨杰拉德的一位分析师将其评级下调至增持，目标股价为885美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly and Co with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro了解礼来公司的最新期权交易，以获取实时提醒。